Every year, World Immunisation Week (WIW) reminds us that vaccines have saved millions of lives over the years. They continue to be crucial to protect us all from preventable diseases. This 2022, it also highlights the relevance of immunisation to contribute to the purpose that we all live a long, healthy life. This is a motto we share and hold dear at Teamit Research. From RESCEU and PROMISE, two IMI projects focused on Respiratory Syncytial virus (RSV) prevention and immunisation in Europe, to vaccine safety studies conducted by VAC4EU, we contribute to global efforts to protect and improve people’s lives all year round. We join this annual campaign and showcase the work being done in some of the projects and studies we are involved in. They all take us a step closer to achieving this shared goal: “Long Life for All”.
Fighting RSV
Respiratory Syncytial virus (RSV) is a common and highly contagious virus. The infection is generally mild, but sometimes can also cause severe respiratory illness and even become life-threatening, especially in babies and older adults. Since 2017, RESCEU has significantly advanced knowledge on medical, social, and economic burden of RSV disease worldwide to better inform public health policies. Its sister project, PROMISE is now paving the way for RSV immunisation and surveillance in Europe to help prevent the severity of this disease.
At Teamit Research, we are highly involved in both IMI projects, mainly in the areas of strategic management and communication and dissemination. You can learn more by visiting RESCUE and PROMISE websites.
This 2022, WIW also highlights the relevance of immunisation to contribute to the purpose that we all live a long, healthy life. This is a motto we share and hold dear at Teamit Research
Generating the best evidence on the safety and efficacy of vaccines
VAC4EU is making an important contribution by generating real-world evidence on the effects of vaccines at the European level. The monitoring and post-approval studies conducted within VAC4EU are crucial to support public health and decision-making.
Teamit Research, through is spin-off Teamit Institute, is a member of the Executive Board of VAC4EU. Our team is deeply involved in several studies assessing the benefit-risk of vaccines. You can visit VAC4EU website for more information on the important work carried out by this European partnership.
Also, if you wish to learn more about how vaccines work, their history, coverage and relevance, we recommend you visit WHO dedicated site.
World immunisation week is organised by the World Health Organization (WHO) with the support of a wide range of partners, including Gavi, the Vaccine Alliance, UNICEF, the Bill & Melinda Gates Foundation and many more large and small organisations like Teamit Research.
